Italy September 26, 2016 Text size Home Who we are Our products Research and development Transparency Orion in English Contact us Business areas Our approach Mission & vision Home / About us Orion products are marketed all over the world, in over one hundred countries. The company's sales network covers 26 European countries. Consolidate the European presence Orion today boasts the presence of its own sales structures in 26 countries and is committed to increasing its operations in Germany and the United Kingdom, increasing investments in Eastern and Central Europe. The company is also expanding its presence in Southern European markets. In fact, in 2009 the branches in Spain, Greece, Portugal and Italy were inaugurated. The Italian branch based in Milan covers the entire national territory with its own sales force and is focused on products divided by therapeutic area. News News (November 16, 2011) Orion Italy Since 2009 Orion Pharma is also present in Italy, where it markets. SIMDAX (levosimendan), a calcium sensitizer, derivative of pyridazinone dinitrile. Levosimendan, combining inotropic and vasodilatory effects, increases cardiac output without increasing oxygen consumption. It is indicated in the short-term treatment of severe chronic heart failure, in the phase of acute instability; KESSAR (tamoxifen citrate), a non-steroidal anti-estrogen, widely used in the adjuvant therapy of breast cancer patients, with positive hormone receptors (estrogen and progesterone); REMIFENTANIL ORION, equivalent drug indicated, as an analgesic agent, for use during the induction and / or maintenance of general anesthesia. Remifentanil is a powerful synthetic opioid with a high speed of action and a short half-life, which significantly reduces the amount of hypnotic drug required to maintain anesthesia FILENA (estradiol valerate + medroxyprogesterone acetate) for the symptomatic treatment of climacteric disorders or hormone replacement therapy; SANDRENA (estradiol hemihydrate) hormone replacement therapy. Treatment of postmenopausal estrogen deficiency symptoms; DEXDOR(dexmedetomidine), an α2-agonist agent used by continuous infusion in adult patients in the Intensive Care Unit (ICU) who require a level of sedation no deeper than awakening in response to verbal stimulation; BEMEDREX EASYHALER (beclomethasone dipropionate), glucocorticoid in a practical multidose inhaler; the powerful local anti-inflammatory activity on the respiratory mucosa makes it effective for the treatment of persistent mild, moderate and severe asthma; CLOZAPINA ORIONis an atypical antipsychotic, dibenzodiazepine derivative, indicated in patients with schizophrenia resistant to treatment with classical or other atypical neuroleptics; it is also used in the therapy of psychotic disorders during Parkinson's disease.. You are leaving the Orion Pharma Italia website. The information contained on the site you are about to access may not comply with Legislative Decree 219/06 which regulates advertising on medicinal products for human use and is in any case completely independent and outside the control of the company which cannot be held responsible in any way. about © Orion Pharma Italia, Via San Gregorio 34, 20124 Milan Telephone +390267876122, Fax 0266703689 Home site map Contact us